U.S. flag

An official website of the United States government

NM_000398.7(CYB5R3):c.478C>T (p.Arg160Ter) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Apr 13, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000578723.4

Allele description [Variation Report for NM_000398.7(CYB5R3):c.478C>T (p.Arg160Ter)]

NM_000398.7(CYB5R3):c.478C>T (p.Arg160Ter)

Gene:
CYB5R3:cytochrome b5 reductase 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q13.2
Genomic location:
Preferred name:
NM_000398.7(CYB5R3):c.478C>T (p.Arg160Ter)
HGVS:
  • NC_000022.11:g.42627674G>A
  • NG_012194.1:g.26726C>T
  • NM_000398.7:c.478C>TMANE SELECT
  • NM_001129819.2:c.409C>T
  • NM_001171660.2:c.577C>T
  • NM_001171661.1:c.409C>T
  • NM_007326.4:c.409C>T
  • NP_000389.1:p.Arg160Ter
  • NP_001123291.1:p.Arg137Ter
  • NP_001165131.1:p.Arg193Ter
  • NP_001165132.1:p.Arg137Ter
  • NP_015565.1:p.Arg137Ter
  • NC_000022.10:g.43023680G>A
  • NM_000398.6:c.478C>T
Protein change:
R137*; ARG160TER
Links:
OMIM: 613213.0015; dbSNP: rs61732609
NCBI 1000 Genomes Browser:
rs61732609
Molecular consequence:
  • NM_000398.7:c.478C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001129819.2:c.409C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001171660.2:c.577C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001171661.1:c.409C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_007326.4:c.409C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000680519GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Apr 13, 2023)
germlineclinical testing

Citation Link,

SCV004300035Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 20, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis.

Aalfs CM, Salieb-Beugelaar GB, Wanders RJ, Mannens MM, Wijburg FA.

Hum Mutat. 2000;16(1):18-22.

PubMed [citation]
PMID:
10874300

Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency.

Percy MJ, Lappin TR.

Br J Haematol. 2008 May;141(3):298-308. doi: 10.1111/j.1365-2141.2008.07017.x. Epub 2008 Mar 3. Review.

PubMed [citation]
PMID:
18318771
See all PubMed Citations (3)

Details of each submission

From GeneDx, SCV000680519.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Published functional studies demonstrate a damaging effect, as variant results in absence of protein due to proteolytic degradation (Davis et al., 2004); This variant is associated with the following publications: (PMID: 23113554, 18318771, 23594618, 29375859, 31898843, 25525159, 15953014, 18202104, 15488472, 10874300)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004300035.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This premature translational stop signal has been observed in individual(s) with methemoglobinemia type II (PMID: 10874300). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 248). This variant is present in population databases (rs61732609, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Arg160*) in the CYB5R3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYB5R3 are known to be pathogenic (PMID: 18318771).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024